New technology is creating novel ways to manage, source and analyze clinical data and could open the door to a new realm of possibility for pharmaceutical companies, CROs and others that rely on huge sets of data to create new health care products.
An upcoming panel discussion at the DIA 2015 51st Annual Meeting will focus on the challenges of building and using registries to recruit subjects for trials on delay-of-onset of mild cognitive impairment due to Alzheimer's disease.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
“Developing Innovative Approaches to Postmarketing Safety Data Collection in Pregnant Women, ” a panel discussion taking place at the DIA 2015 51st Annual Meeting, will explore the challenges of conducting postmarketing studies in pregnant women.
When it comes to retaining subjects already enrolled in trials, mHealth/mClinical offers tremendous opportunities for making it easier for participants to stay engaged throughout the study and potentially provides avenues for collecting higher quality data.
Regenerative medicines and the latest regulatory issues surrounding them will be a hot topic for discussion at the DIA 2014 50th Annual Meeting. A session titled “Pioneering Regenerative Medicine: Trends in Regulations for New Therapy” will introduce the first clinical research of induced pluripotent stem (iPS) cell products in Japan.
A session at the DIA 2014 50th Annual Meeting will discuss the need for a common framework and approach to the review of medicines and address the challenges and opportunities for developing a systematic structured approach to benefit-risk assessment.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
The DIA 2014 50th Annual Meeting will highlight The Blue Button Project, which empowers patients to use their individual electronic clinical data to improve their overall health and wellness, from sharing data with health care providers to powering clinical risk assessment tools.
The DIA 2014 50th Annual Meeting: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.
DIA 2013 49th Annual Meeting will be held in Boston, Mass. from June 23-27, and will feature a session titled “Defining Clinical Trial Innovation: Challenges and Opportunities for 2013” under the Communities Showcase track. The forum, developed by the DIA’s Clinical Research Community, will give participants the chance to discuss the challenges and opportunities for innovation to improve global health and fulfill unmet medical needs.
The DIA 2013 49th Annual Meeting, to be held in Boston, Mass., from June 23-27, is the largest life sciences meeting in North America. Among the 250+ educational offerings across 22 tracks will be a session titled “Co-development of Targeted Therapies and Companion Diagnostics: Identifying Regulatory Strategies to Overcome Challenges” within the Medical Devices, In Vitro Diagnostics, and Combination Products track.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
There are many challenges to overcome to develop and disseminate technology to health care providers and decision-makers. The largest, multidisciplinary life sciences meeting in North America, the DIA 2013 49th Annual Meeting, will give attendees the opportunity to discuss these issues and hear about innovative solutions. DIA 2013 49th Annual Meeting, to be held in Boston, Mass., from June 23-27, will feature a session titled “Unique Nonprofit-Industry Partnerships to Develop and Disseminate Technology”, under the Innovative Partnering Models and Outsourcing Strategies track.